- Home
- / Latigo Biotherapeutics
Latigo Biotherapeutics
Total Funding
$135 M
Latigo Biotherapeutics Summary
Company Summary
- Overview
- Latigo Biotherapeutics is a biotechnology company specializing in drug development solutions. It focuses on developing non-opioid pain medicines for targeting pain transduction.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Thousand Oaks, CA, US | view all locations
- Website
- https://latigobio.com/
- Cybersecurity rating
Table of Contents
Key People
Bryan Moyer, Senior Vice President, Discovery
Holly Carlisle, Vice President, Translational Science
Mike Kaufman, Vice President, Chemistry
LocationsView all
1 location detected
Thousand Oaks, CA HQ
United States
1300 Rancho Conejo Blvd, Suite 305